Internal Medicine · Columbus, GA
NPI
1629162490
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2100 Comer Ave
Columbus, GA, 31904
Phone (706) 321-6300
Groups this clinician bills Medicare through
Medicare paid, 2023
$2,136
43 services
Medicare patients, 2023
25
Average age 58
Drug cost, 2024
$7.2M
3,198 prescriptions
Company payments, 2025
$59.21
From 1 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Audrey W Brown was code 99213 (office e&m - established), 22 times for 16 patients. In total Audrey W Brown billed 43 services in 3 codes, and Medicare paid $2,136.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 22 | 16 | $41.69 | $917 |
| 99214 Office E&M - Established | Office | 20 | 17 | $55.91 | $1,118 |
By year: 2022 $1,913 for 40 services; 2023 $2,136 for 43 services.
Medicare prescription drug claims, 2024
In 2024, the drug Audrey W Brown prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 628 prescriptions and refills. In total Audrey W Brown wrote 3,198 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 628 | 628 | 72 | $2.5M |
| Tivicay Dolutegravir Sodium | 416 | 416 | 49 | $899K |
| Prezcobix Darunavir/Cobicistat | 218 | 218 | 25 | $513K |
| Descovy Emtricitabine/Tenofov Alafenam | 202 | 202 | 21 | $429K |
| Ritonavir Generic | 171 | 181 | 20 | $14K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 167 | 167 | 17 | $666K |
| Darunavir Generic | 140 | 140 | 16 | $159K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 112 | 112 | Under 11 | $413K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 107 | 107 | 14 | $486K |
| Juluca Dolutegravir/Rilpivirine | 99 | 99 | Under 11 | $341K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 97 | 98 | 17 | $807 |
| Dovato Dolutegravir Sodium/Lamivudine | 95 | 95 | 12 | $278K |
| Atorvastatin Calcium Generic | 66 | 96 | 12 | $215 |
| Pifeltro Doravirine | 54 | 54 | Under 11 | $94K |
| Rosuvastatin Calcium Generic | 51 | 57 | Under 11 | $129 |
Brand drugs: 2,264 claims; generic drugs: 934 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Audrey W Brown $59.21 ($59.21 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $59.21.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $59.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.